TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $361,900 | +218.2% | 241,266 | +111.9% | 0.00% | – |
| Q4 2022 | $113,724 | -38.5% | 113,861 | +10.6% | 0.00% | – |
| Q3 2022 | $185,000 | -38.3% | 102,921 | -0.4% | 0.00% | – |
| Q2 2022 | $300,000 | +4.9% | 103,354 | -0.3% | 0.00% | – |
| Q1 2022 | $286,000 | +28500.0% | 103,698 | +37608.4% | 0.00% | – |
| Q4 2021 | $1,000 | -99.9% | 275 | -99.9% | 0.00% | – |
| Q3 2021 | $1,886,000 | -72.9% | 221,635 | -47.8% | 0.00% | -100.0% |
| Q2 2021 | $6,971,000 | -31.2% | 424,800 | -7.4% | 0.00% | 0.0% |
| Q1 2021 | $10,128,000 | -28.6% | 458,700 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $14,188,000 | +77.9% | 458,700 | +16.9% | 0.00% | 0.0% |
| Q3 2020 | $7,976,000 | +797500.0% | 392,500 | +503105.1% | 0.00% | – |
| Q3 2019 | $1,000 | – | 78 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
| MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
| TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
| Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
| K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
| HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
| Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
| Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
| Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
| X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |